When the U.S. Food and Drug Administration (FDA) first approved the anti-coagulant dabigatran – sold by German pharmaceutical firm Boehringer-Ingelheim (BI) under the brand name Pradaxa…

Various media sources recently announced that an experimental antidote for Pradaxa – an anticoagulant implicated in bleeding deaths – has successfully reversed the effects of the drug in healthy…

German pharmaceutical giant Boehringer-Ingelheim (BI) is trumpeting the news across the world: their flagship product, Pradaxa (dabigatran), approved in 100 countries around the world for stroke…

Followers of Ring of Fire radio probably noticed a disturbing report recently about Boehringer-Ingelheim's (BI) efforts to expand the use of its anticoagulant drug, Pradaxa (dabigatran)…

Recently, the FDA issued a report, based in part on data from the questionable RE-LY study, stating that…

It's already widely-known that Boehringer-Ingelheim's anti-coagulant drug, Pradaxa, carries a high risk of patients bleeding to death – and, to add insult to injury, costs that are fifteen times…

These words, the first bit of advice given to space travelers in the late Douglas Adams' Hitchhiker's Guide to the Galaxy, were also issued to the medical community recently regarding the…

There is much to admire about modern Germany. Their citizens enjoy protections and support systems such as guaranteed health care, six weeks paid vacation every year, green energy initiatives and…